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Abstract
Endocrine disruptors is an issue with great importance toxicological. 
Among them, there is bisphenol A (BPA) and its possible contributing 
towards the development of polycystic ovary syndrome (PCOS). Ani-
mal studies and cross-sectional models in humans demonstrate the 
harmful effects from exposure to BPA and drive the need to seek 
environmentally safe and healthy alternative to the use of BPA.
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Endocrine-disrupting compounds (EDCs) comprise a wide range of 
natural and synthetic compounds, which exhibit a potential to elicit 
negative effects on endocrine systems acting as mimics or antagonists 
of endogenous hormones, and, thus, may cause health effects in 
people and wildlife. They can cause adverse effects by interfering in 
some way with the body’s hormones and may induce a broad spec-
trum of toxic responses at low environmentally relevant doses. These 
effects are of particular environmental concern since the middle of the 
1990s. EDCs include natural and synthetic (anti)estrogens and (anti)an-
drogens, pharmaceuticals, pesticides, industrial chemicals, and heavy 
metals. Many of these EDCs have been shown to have the ability to 
bind to estrogen or androgen receptors, thus disrupting the normal 
endocrine functions in organisms [1-6].
One of the most studied EDCs is bisphenol A (BPA; 2,2-bis (4-hydro-
xyphenol) propane). BPA was first synthesized by Dianin in 1891, and 
its estrogenic activity was discovered in 1936. In the 1950s, it was ob-
served that BPA could be polymerized to make polycarbonate plastic, 
a miraculous cheap product that is lightweight, transparent, colorable, 
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resistant to impact, heat, and chemicals, inalterable 
with time, and easy to mold and thermoform. BPA 
can leach from food or beverage containers and 
is then ingested. This is the main source of conta-
mination, although its ubiquitous distribution leads 
also to contamination through the skin, especially 
in the case of thermal paper [7], or via inhalation of 
household dusts [8].
Animal studies indicate that BPA affects repro-
duction, however, the gene-environment interac-
tion mechanism(s) involved in this association rema-
ins unclear. Evidence shows that BPA can interfere 
with endocrine function of hypothalamic-pituitary 
axis, such as by changing gonadotropin-releasing 
hormones (GnRH) secretion in hypothalamus and 
promoting pituitary proliferation. Such actions 
affect puberty, ovulation and may even result in 
infertility. Ovary, uterus and other reproductive or-
gans are also targets of BPA. BPA exposure impairs 
the structure and functions of female reproductive 
system in different times of life cycle and may con-
tribute to infertility. Both epidemiological and ex-
perimental evidences demonstrate that BPA affects 
reproduction-related gene expression and epige-
netic modification that are closely associated with 
infertility. The detrimental effects on reproduction 
may be lifelong and transgenerational [9].
Recently, there has been interest in whether en-
docrine-disrupting chemicals (EDCs) in the environ-
ment, particularly Bisphenol A (BPA), may contribute 
to the development of polycystic ovary syndrome 
(PCOS), which represents a common endocrine di-
sorder among women of reproductive age. With 
a lack of a clear etiology for its generative roots, 
PCOS is now considered to enclose genetic and 
environmental components [10] leading to pheno-
typic variability. Traditionally, women with PCOS 
manifest both reproductive (chronic anovulation, 
hyperandrogenism, polycystic ovarian morphology) 
and metabolic (insulin resistance, metabolic syndro-
me, obesity) derangements. However, there is much 
heterogeneity of clinical and biochemical features 
raising the possibility that a cluster of etiological 
factors synergistically contribute to the final PCOS 
phenotype. In animal models, exposure to BPA du-
ring the perinatal period dramatically disrupts ova-
rian and reproductive function in females, often at 
doses similar to typical levels of human exposure. 
BPA also appears to have obesogenic properties, 
disrupting normal metabolic activity and making 
the body prone to overweight. In humans, cross-
sectional data suggest that BPA concentrations are 
higher in women with PCOS than in reproductively 
healthy women, but the direction of causality has 
not been established [11, 12].
Due to the already known hazards caused by the 
exposure to BPA and the association to the variabili-
ty of phenotypes in the PCOS, it is necessary to find 
low-cost, environmental safe and healthy alternati-
ves to BPA. More biomonitoring studies are required 
to evaluate long term effects of the exposure to 
BPA, as most evidences are inconclusive.
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